Anthracyclines

checkpoint kinase 2 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27708748 Prevalence of the CHEK2 R95* germline mutation. 2016 1
2 25414026 Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers. 2014 Dec 1
3 22420423 Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. 2012 Mar 15 3